Sanofi SA

SAN: XPAR (FRA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
&dzLOCK|BKyv@LOCK|C^W?@&G

Sanofi Earnings: Strong Earnings Growth Supports Optimistic Full-Year Guidance

Sanofi reported net sales growth of 7% at constant currency and business earnings per share growth of 13%. Despite lower flu vaccine sales, Dupixent and Altuviiio continued to drive growth, and management reiterated its full-year guidance of low-double-digit business EPS growth.

Sponsor Center